24-Month Phase I/II Clinical Trial of Bimatoprost Sustained-Release Implant (Bimatoprost SR) in Glaucoma Patients

OBJECTIVE: The objective of this study was to evaluate the safety and intraocular pressure (IOP)-lowering effects over 24 months of biodegradable bimatoprost sustained-release implant (Bimatoprost SR) administration versus topical bimatoprost 0.03% in patients with open-angle glaucoma (OAG). METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Craven, E. Randy, Walters, Thomas, Christie, William C., Day, Douglas G., Lewis, Richard A., Goodkin, Margot L., Chen, Michelle, Wangsadipura, Veronica, Robinson, Michael R., Bejanian, Marina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7007425/
https://www.ncbi.nlm.nih.gov/pubmed/31884564
http://dx.doi.org/10.1007/s40265-019-01248-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7007425/
https://www.ncbi.nlm.nih.gov/pubmed/31884564
http://dx.doi.org/10.1007/s40265-019-01248-0

Ejemplares similares